肝硬化患者肝内胆管癌:钆塞酸增强MR成像与动态CT鉴别肝细胞癌
回顾性分析72例肝硬化患者78个肝内胆管癌与匹配的77个肝细胞癌,评估钆塞酸增强MR和CT鉴别诊断效能。MR采用门静脉期廓清替代常规廓清可将诊断HCC特异度提升至100%,但敏感度从76.6%降至63.6%(增强标准)或从64.9%降至55.8%(mLI-RADS),CT常规廓清敏感度72.7%、特异度97.4%。
要点
- 钆塞酸增强MR使用门静脉期廓清可避免将肝内胆管癌误判为肝细胞癌,但会降低肝细胞癌诊断敏感度。
- MR常规廓清条件下,增强标准诊断HCC特异度94.9%,mLI-RADS特异度96.2%。
- CT常规廓清诊断HCC敏感度72.7%、特异度97.4%(增强标准),mLI-RADS敏感度67.5%、特异度97.4%。
核心结论
- 在钆塞酸增强MR成像中,采用门静脉期廓清替代常规廓清可防止肝硬化肝脏中肝内胆管癌被误分类为肝细胞癌,但会导致肝细胞癌诊断敏感度下降。
研究设计与样本
- 回顾性研究,纳入72例连续患者(61名男性,平均年龄56.6岁)共78个肝内胆管癌,与一对一匹配的对照患者(56名男性,平均年龄56.6岁)共77个肝细胞癌;由两名独立阅片者评估钆塞酸增强MR和CT图像,采用单因素和多因素分析。
诊断标准与关键数值
- MR常规廓清时,增强标准诊断HCC敏感度76.6%(59/77)、特异度94.9%(74/78);mLI-RADS敏感度64.9%(50/77)、特异度96.2%(75/78)。MR门静脉期廓清时,增强标准敏感度63.6%(49/77)、特异度100%(78/78);mLI-RADS敏感度55.8%(43/77)、特异度100%(78/78),敏感度下降P ≤ .016。CT常规廓清时,增强标准敏感度72.7%(56/77)、特异度97.4%(76/78);mLI-RADS敏感度67.5%(52/77)、特异度97.4%(76/78)。
临床应用与阅片要点
- 在肝硬化患者中,钆塞酸增强MR采用门静脉期廓清而非常规廓清,可提高排除肝内胆管癌的特异度,但需注意肝细胞癌诊断敏感度随之降低。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To determine the imaging features at gadoxetic acid-enhanced magnetic resonance (MR) imaging of intrahepatic cholangiocarcinoma (IHCC) in a cirrhotic liver, with an emphasis on the distinction between IHCC and hepatocellular carcinoma (HCC) and on the comparison of nodule enhancement patterns between MR imaging and computed tomography (CT). Materials and Methods The institutional review board approved this study and waived the requirement for informed consent. Gadoxetic acid-enhanced MR and CT images in 72 consecutive patients (61 men; mean age, 56.6 years) with 78 IHCCs and one-to-one matched control patients (56 men; mean age, 56.6 years) with 77 HCCs were evaluated retrospectively by two independent readers. Findings that could differentiate IHCC from HCC were evaluated with univariate and multivariate analyses. Using the enhancement criteria and the Liver Imaging Reporting and Data System with modifications (mLI-RADS), the sensitivity and specificity for diagnosing HCC were calculated with conventional washout and portal venous phase (PVP) washout. Results At MR imaging with conventional washout, the specificities for diagnosing HCC were 94.9% (74 of 78) with the enhancement criteria and 96.2% (75 of 78) with mLI-RADS, while the use of PVP washout achieved 100% (78 of 78) specificity for diagnosing HCC with both diagnostic criteria at the expense of decreased sensitivity (from 76.6% [59 of 77] to 63.6% [49 of 77] with the enhancement criteria and from 64.9% [50 of 77] to 55.8% [43 of 77] with mLI-RADS, P ≤ .016). At CT, the sensitivities and specificities with conventional washout were 72.7% (56 of 77) and 97.4% (76 of 78), respectively, with the enhancement criteria and 67.5% (52 of 77) and 97.4% (76 of 78), respectively, with mLI-RADS. Conclusion The use of PVP washout instead of conventional washout at gadoxetic acid-enhanced MR imaging prevents the misclassification of IHCC as HCC in a cirrhotic liver but leads to a decreased sensitivity for HCC. © RSNA, 2016 Online supplemental material is available for this article.
引用
- Choi SH, Lee SS, Kim SY, et al. Intrahepatic Cholangiocarcinoma in Patients with Cirrhosis: Differentiation from Hepatocellular Carcinoma by Using Gadoxetic Acid-enhanced MR Imaging and Dynamic CT. Radiology. 2016. PMID: 27797675. doi:10.1148/radiol.2016160639
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。